What if you could predict the risk of breast cancer?

CLAIRITY BREAST

CLAIRITY BREAST is the first FDA-authorized AI platform that predicts a woman’s five-year future risk of developing breast cancer, using only her existing screening mammogram.

“For more than 60 years, mammograms have saved lives by detecting early-stage cancers. Now, advancements in AI and computer vision can uncover hidden clues in the mammograms – invisible to the human eye – to help predict future risk. By delivering validated, equitable risk assessments, we can help expand access to life-saving early detection and prevention for women everywhere.”

Dr. Connie Lehman

Latest News

News

Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion

Clairity, Inc., a pioneer in AI-based predictive tools for breast cancer, is pleased to announce the appointment of Jeffrey R. Luber, JD, MBA, as President, Chief Executive Officer and Director. Luber, an award-winning healthcare leader with extensive experience across oncology, genetic sequencing, infectious disease testing and digital health, will guide Clairity through market launch and global expansion.

Read More »

Be the First to Know

CLAIRITY BREAST is launching soon.
Be the first to know when it launches, and how you can get it.